Using AI, we identified publications that likely reported a testing or mutation rate, filtered publications for cancer type, and identified sentences that likely reported rates. Rates and covariates ...
Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, promising faster diagnoses and cheaper testing. But new research from the ...
Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in Solutions We matched 147 multigene panel patients to controls, ...
The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...
@mooner As a heads up on the genetic testing, I suggest bringing (or better yet also uploading to MyChart) the contact information for the pathologist who identified ameloblastoma. MDA was able to get ...
Suggested Citation: "Appendix C: Lynch Syndrome Topic Brief." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press ...
BRAF-positive non-small cell lung cancer (NSCLC) treatments can use the BRAF biomarker to provide effective, targeted treatment for this subset of lung cancer. BRAF-positive NSCLC is an uncommon or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results